Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the effect of mifepristone on the expression of three cervical EP3 receptor isoforms (EP3-2, EP3-3 and EP3-6) in pregnant women ≤63 days gestational age.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Southern California
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
NCT06397794 · Lyme Disease, Post Treatment Lyme Disease, and more
NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more
NCT07233278 · Recurrent Pregnancy Loss(RPL), Anxiety
NCT05444283 · Recurrent Pregnancy Loss
Women's and Children's Hospital, Reproductive Research Center
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions